Literature DB >> 21071729

Morphometric characteristics of central retinal artery and vein endothelium in the normal human optic nerve head.

Min H Kang1, Chandrakumar Balaratnasingam, Paula K Yu, William H Morgan, Ian L McAllister, Stephen J Cringle, Dao-Yi Yu.   

Abstract

PURPOSE: This study documents the morphometric features of arterial and venous endothelia in the different laminar regions of the normal human optic nerve head and speculates on the hemodynamic characteristics of the central retinal artery (CRA) and central retinal vein (CRV).
METHODS: Twenty normal human eyes were used. Microcannulation techniques were used to label the cytoskeleton and nuclei of endothelial cells in the CRA and CRV, after which images were captured using confocal microscopy. Length, width, length-to-width ratio, and area measurements were obtained from endothelium and its nuclei. Nucleus position with respect to cell apex and direction of blood flow was also quantified. Comparisons were made between prelaminar, anterior lamina cribrosa, posterior lamina cribrosa, and retrolaminar regions. Venous and arterial endothelial cell morphology was also compared.
RESULTS: There was significant variation in venous endothelial morphology across the different laminar regions; however, no differences were found in arterial endothelial characteristics (all P > 0.1065). Significant differences were found between arterial and venous endothelium in all laminar regions apart from the posterior lamina cribrosa, where only nuclear area (P = 0.0001) and nucleus position (P = 0.0088) were found to be different.
CONCLUSIONS: Arterial-like appearance of venous endothelium in the posterior lamina cribrosa, where pressure gradient forces are predicted to be greatest and CRV luminal diameter is known to be narrowest, implicates this as a site of altered hemodynamic stress. Heterogeneity of venous endothelium may have relevance for understanding ocular vascular diseases such as central retinal vein occlusion.

Entities:  

Mesh:

Year:  2011        PMID: 21071729     DOI: 10.1167/iovs.10-6366

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

1.  Venous oxygen saturation is reduced and variable in central retinal vein occlusion.

Authors:  Thorunn Scheving Eliasdottir; David Bragason; Sveinn Hakon Hardarson; Gudrun Kristjansdottir; Einar Stefánsson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-11-18       Impact factor: 3.117

2.  Evaluation of lamina cribrosa thickness in patients diagnosed with central retinal vein occlusion.

Authors:  Orhan Altunel; Mustafa Atas; Süleyman Demircan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-07-03       Impact factor: 3.117

3.  Higher optic nerve sheath diameters are associated with lower ocular blood flow velocities in glaucoma patients.

Authors:  Koen Willekens; Luís Abegão Pinto; Evelien Vandewalle; Carlos Marques-Neves; Ingeborg Stalmans
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-11-27       Impact factor: 3.117

4.  Optic nerve head astrocytes contribute to vascular associated effects.

Authors:  Yanmin Dong; Yue Fu; Xiaobing Qian; Leilei Lin; Yongguang Yuan; Yujie Li; Wanwen Shao; Qianying Gao
Journal:  Front Med (Lausanne)       Date:  2022-07-26

5.  Intraocular Pressure Reduction Is Associated with Reduced Venous Pulsation Pressure.

Authors:  William H Morgan; Philip H House; Martin L Hazelton; Brigid D Betz-Stablein; Balwantray C Chauhan; Ananth Viswanathan; Dao-Yi Yu
Journal:  PLoS One       Date:  2016-01-29       Impact factor: 3.240

Review 6.  Mystery of Retinal Vein Occlusion: Vasoactivity of the Vein and Possible Involvement of Endothelin-1.

Authors:  Teruyo Kida
Journal:  Biomed Res Int       Date:  2017-08-20       Impact factor: 3.411

Review 7.  Chorioretinal Anastomosis for Central Retinal Vein Occlusion: A Review of Its Development, Technique, Complications, and Role in Management.

Authors:  Ian L McAllister
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2020 May-Jun
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.